Abstract
In rectal cancer patients, the stage of the disease, local spread and distant metastases status drive the treatment decisions to be made. Histopathology remains the gold standard, but preoperative staging, particularly magnetic resonance imaging (MRI), is pivotal for defining surgical planes and finding patients who could potentially benefit from preoperative regimes. Unfortunately, due to a lack of awareness, expertise and practise the quality of rectal cancer MRI and histopathology reporting varies among centres. This paper highlights the most important and frequently occurring radiological and histopathological discrepancies/mistakes to be aware of.
Similar content being viewed by others
References
Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery–the clue to pelvic recurrence? Br J Surg 69:613–616
Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2:996–999
Taylor FG, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 253:711–719
Ngan SY, Burmeister B, Fisher RJ et al (2012) Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol 30:3827–3833
Mercury Study Group (2006) Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 14:779
Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G (2008) Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 95:229–236
Chand M, Swift RI, Chau I, Heald RJ, Tekkis PP, Brown G (2014) Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancer. Ann R Coll Surg Engl 96:543–546
Smith NJ, Shihab O, Arnaout A, Swift RI, Brown G (2008) MRI for detection of extramural vascular invasion in rectal cancer. AJR Am J Roentgenol 191:1517–1522
McDonald JR, Renehan AG, O’Dwyer ST, Haboubi NY (2012) Lymph node harvest in colon and rectal cancer: current considerations. World J Gastrointest Surg 4:9–19
Haboubi N, Berho M (2014) Lymph node harvest (LNH) in colorectal cancer; a critical appraisal. Pol Przegl Chir 86:497–504
Markl B, Wieberneit J, Kretsinger H et al (2016) Number of intratumoral T lymphocytes is associated with lymph node size, lymph node harvest, and outcome in node-negative colon cancer. Am J Clin Pathol 145:826–836
Markl B, Schaller T, Kokot Y et al (2015) Lymph node size as a simple prognostic factor in node negative colon cancer and an alternative thesis to stage migration. Am J Surg 212:775–780
Brown G, Richards CJ, Bourne MW et al (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227:371–377
Chand M, Heald RJ, Brown G (2013) The importance of not overstaging mesorectal lymph nodes seen on MRI. Colorectal Dis 15:1201–1204
Chand M, Bhangu A, Wotherspoon A et al (2014) EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy. Ann Oncol 25:858–863
Shihab OC, Quirke P, Heald RJ, Moran BJ, Brown G (2010) Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision. Br J Surg 97:1431–1436
Knijn N, van Erning FN, Overbeek LI et al (2016) Limited effect of lymph node status on the metastatic pattern in colorectal cancer. Oncotarget 7:31699–31707
Chand M, Evans J, Swift RI et al (2015) The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann Surg 261:473–479
Loughrey MB, Quirke P, Shepherd NA (2014) Dataset for colorectal cancer histopathology reports. R Coll Pathol. http://www.rcpath.org/Resources/RCPath/MigratedResources/Documents/G/G049_ColorectalDataset_July14.pdf
Messenger DE, Driman DK, Kirsch R (2012) Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome. Hum Pathol 43(7):965–973. doi:10.1016/j.humpath.2011.11.015
Balyasnikova JR, Swift I, Wotherspoon A, Tait D, Brown G (2014) MRI staging of early rectal cancer. Paper presented at the ESCP, 2014, Barcelona, Spain
Absar MS, Haboubi NY (2004) Colonic neoplastic polyps: biopsy is not efficient to exclude malignancy. The Trafford experience. Tech Coloproctol 8(Suppl 2):s257–s260
Serra-Aracil X, Caro-Tarrago A, Mora-Lopez L, Casalots A, Rebasa P, Navarro-Soto S (2014) Transanal endoscopic surgery with total wall excision is required with rectal adenomas due to the high frequency of adenocarcinoma. Dis Colon Rectum 57:823–829
Jeziorska M, Haboubi NY, Schofield PF, Ogata Y, Nagase H, Woolley DE (1994) Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma. Int J Colorectal Dis 9:141–148
Haboubi N (2013) Experienced histopathologists can accurately diagnose colorectal carcinoma in the absence of Muscularis Mucosa. Colorectal Dis 15(5):78
Haboubi N, Salmo E (2013) Are we accurately measuring the depth of the submucosal invasion in early colorectal cancer by equating the Kikuchi submucosa levels with distances measured in fractions of a millimetre? Colorectal Dis 15:775–777
Taylor FG, Quirke P, Heald RJ, Mercury study gruop et al (2011) One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br J Surg 98:872–879
Shihab OC, How P, West N et al (2011) Can a novel MRI staging system for low rectal cancer aid surgical planning? Dis Colon Rectum 54:1260–1264
Moran BJ, Holm T, Brannagan G et al (2014) The English national low rectal cancer development programme: key messages and future perspectives. Colorectal Dis 16:173–178
Morris KA, Haboubi NY (2015) Pelvic radiation therapy: between delight and disaster. World J Gastrointest Surg 7:279–288
Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23:6126–6131
Patel UB, Blomqvist LK, Taylor F et al (2012) MRI after treatment of locally advanced rectal cancer: how to report tumor response–the MERCURY experience. AJR Am J Roentgenol 199:W486–W495
Siddiqui MR, Gormly KL, Bhoday J et al (2016) Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). Clin Radiol 71:854–862
Rutten H, Glynne-Jones R, Rullier E et al (2006) Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: results of an international multicenter phase II study. J Clin Oncol 24 (153 suppl) abstr 3528
Patel UB, Taylor F, Blomqvist L et al (2011) Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 29:3753–3760
Battersby NJ, Moran B, Stelzner S et al (2016) Reply to: does MRI restaging of rectal cancer after chemoradiotherapy actually permit a change in surgical management? Ann Surg. doi:10.1097/SLA.0000000000001791
Nagtegaal I, Gaspar C, Marijnen C, Van De Velde C, Fodde R, Van Krieken H (2004) Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour. J Pathol 204:183–192
Yu SK, Chand M, Tait DM, Brown G (2014) Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy. Eur J Cancer 50:920–927
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Balyasnikova, S., Haboubi, N., Moran, B. et al. Histopathological and radiological reporting in rectal cancer: concepts and controversies, facts and fantasies. Tech Coloproctol 21, 15–23 (2017). https://doi.org/10.1007/s10151-016-1555-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-016-1555-y